Sign in

CIK 0001517022

  • Large accelerated filer

Akebia Therapeutics, Inc.

Sign in to watch
Ticker
AKBA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
208756903
Phone
+1 617-871-2098
Business address
180 THIRD AVENUE, FLOOR 2, WALTHAM, MA, 02451
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-06-29 Ostrowski Erik SVP, CFO, CBO & Treasurer Sale 10b5-1 −56,019 $1.11 $62K 616,616
2026-02-02 Ostrowski Erik SVP, CFO, CBO & Treasurer Sale 10b5-1 −34,951 $1.39 $49K 672,635
2026-01-30 Ostrowski Erik SVP, CFO, CBO & Treasurer Grant or award +204,000 707,586
2026-01-30 Ostrowski Erik SVP, CFO, CBO & Treasurer Grant or award · Stock Option (Right to buy) +320,000 320,000
2025-06-30 Ostrowski Erik SVP, CFO, CBO & Treasurer Sale 10b5-1 −41,314 $3.67 $152K 503,586
2025-01-31 Ostrowski Erik SVP, CFO, CBO & Treasurer Grant or award +194,900 544,900
2025-01-31 Ostrowski Erik SVP, CFO, CBO & Treasurer Grant or award · Stock Option (Right to buy) +292,300 292,300
2024-06-28 Ostrowski Erik SVP, CFO, CBO & Treasurer Grant or award +350,000 350,000
2024-06-28 Ostrowski Erik SVP, CFO, CBO & Treasurer Grant or award · Stock Option (Right to buy) +500,000 500,000

Page 1 of 1 · 9 trades